相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heterogeneity in DCE-MRI parametric maps: a biomarker for treatment response?
L. Alic et al.
PHYSICS IN MEDICINE AND BIOLOGY (2011)
Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix
S. B. Donaldson et al.
BRITISH JOURNAL OF CANCER (2010)
Impact of Dynamic 18F-FDG PET on the Early Prediction of Therapy Outcome in Patients with High-Risk Soft-Tissue Sarcomas After Neoadjuvant Chemotherapy: A Feasibility Study
Antonia Dimitrakopoulou-Strauss et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status
William D. Foulkes et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Quantifying Antivascular Effects of Monoclonal Antibodies to Vascular Endothelial Growth Factor: Insights from Imaging
James P. B. O'Connor et al.
CLINICAL CANCER RESEARCH (2009)
Assessment of the spatial pattern of colorectal tumour perfusion estimated at perfusion CT using two-dimensional fractal analysis
Vicky Goh et al.
EUROPEAN RADIOLOGY (2009)
Quantifying Spatial Heterogeneity in Dynamic Contrast-Enhanced MRI Parameter Maps
Chris J. Rose et al.
MAGNETIC RESONANCE IN MEDICINE (2009)
Optimizing functional parameter accuracy for breath-hold DCE-MRI of liver tumours
Matthew R. Orton et al.
PHYSICS IN MEDICINE AND BIOLOGY (2009)
Exploring feature-based approaches in PET images for predicting cancer treatment outcomes
I. El Naqa et al.
PATTERN RECOGNITION (2009)
PET/CT Assessment of Response to Therapy: Tumor Change Measurement, Truth Data, and Error
Paul E. Kinahan et al.
TRANSLATIONAL ONCOLOGY (2009)
Quantitative Imaging to Assess Tumor Response to Therapy: Common Themes of Measurement, Truth Data, and Error Sources
Charles R. Meyer et al.
TRANSLATIONAL ONCOLOGY (2009)
Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-Gluco-RGD autoradiography
Maria Picchio et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas
Tobias Klatte et al.
JOURNAL OF UROLOGY (2008)
Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives
James P. B. O'Connor et al.
LANCET ONCOLOGY (2008)
Tracer kinetic model-driven registration for dynamic contrast-enhanced MRI time-series data
Giovanni A. Buonaccorsi et al.
MAGNETIC RESONANCE IN MEDICINE (2007)
Enhancing fraction predicts clinical outcome following first-line chemotherapy in patients with epithelial ovarian carcinoma
James P. B. O'Connor et al.
CLINICAL CANCER RESEARCH (2007)
Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging
Alan Jackson et al.
CLINICAL CANCER RESEARCH (2007)
DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
J. P. B. O'Connor et al.
BRITISH JOURNAL OF CANCER (2007)
Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI
Geoff J. M. Parker et al.
MAGNETIC RESONANCE IN MEDICINE (2006)
FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma
L. F. de Geus-Oei et al.
ANNALS OF ONCOLOGY (2006)
Comparison of the performance of tracer kinetic model-driven registration for dynamic contrast enhanced MRI using different models of contrast enhancement
Giovanni A. Buonaccorsi et al.
ACADEMIC RADIOLOGY (2006)
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
O Casanovas et al.
CANCER CELL (2005)
Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat
T Schroeder et al.
CANCER RESEARCH (2005)
Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram from dynamic contrast-enhanced MRI
YC Chang et al.
PHYSICS IN MEDICINE AND BIOLOGY (2004)
Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging
SM Galbraith et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging
SP Robinson et al.
BRITISH JOURNAL OF CANCER (2003)
Metapopulation dynamics and spatial heterogeneity in cancer
I González-García et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer
ML George et al.
BRITISH JOURNAL OF SURGERY (2001)
分享论文
